Protein based COVID-19 vaccine

Description

In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains the recombinant protein nanoparticle COVID-19 vaccine with a proprietary adjuvant, including the mechanism of action, efficacy, and tolerability; and provides an update on boosters, indications, and access
(8 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Paige Lanyon-Roberts

Dr Paige Lanyon-Roberts

The New Oral Medications for Obesity – A Practical Guide for GPs

Dr Terri-Lynne South

Dr Terri-Lynne South

Oral GLP1s – What GPs Need to Know

Dr Katherine Spira

Dr Katherine Spira

Menstrual Migraine

Prof Danny Green

Prof Danny Green

GLP1s and Muscle Mass – What Does the Evidence Show?

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Paul Griffin

expert

Prof Paul Griffin

Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland

Date published: 12 July 2023